Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with Associated Impact on Outcome Kritharis, A., Kanakry, J. A., Sehn, L. H., Feldman, T., Kroll, A., Gascoyne, R. D., Petrich, A. M., Abramson, J. S., Hernandez-Ilizaliturri, F., Al-Mansour, Z., Adeimy, C., Hemminger, J., Bartlett, N. L., Mato, A. R., Caimi, P., Advani, R., Klein, A. K., Lossos, I. S., Press, O. W., Smith, S. M., Fabregas, J. C., Nabhan, C., Fenske, T. S., Friedberg, J. W., Vose, J. M., Blum, K. A., Evens, A. M. AMER SOC HEMATOLOGY. 2014

View details for Web of Science ID 000349243505124